145 related articles for article (PubMed ID: 2668243)
1. Synthesis and antimicrobial evaluation of 20-deoxo-20-(3,5-dimethylpiperidin-1-yl)desmycosin (tilmicosin, EL-870) and related cyclic amino derivatives.
Debono M; Willard KE; Kirst HA; Wind JA; Crouse GD; Tao EV; Vicenzi JT; Counter FT; Ott JL; Ose EE
J Antibiot (Tokyo); 1989 Aug; 42(8):1253-67. PubMed ID: 2668243
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity studies of 20-deoxo-20-amino derivatives of tylosin-related macrolides.
Kirst HA; Willard KE; Debono M; Toth JE; Truedell BA; Leeds JP; Ott JL; Felty-Duckworth AM; Counter FT; Ose EE
J Antibiot (Tokyo); 1989 Nov; 42(11):1673-83. PubMed ID: 2684947
[TBL] [Abstract][Full Text] [Related]
3. In vitro antibacterial properties of EL-870, a new semi-synthetic macrolide antibiotic.
Ose EE
J Antibiot (Tokyo); 1987 Feb; 40(2):190-4. PubMed ID: 3570967
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo evaluation of C-20- and C-23-modified derivatives of tylosin against veterinary pathogens.
Kirst HA; Ose EE; Toth JE; Willard KE; Debono M; Felty-Duckworth AM; Pekarek RS
J Antibiot (Tokyo); 1988 Jul; 41(7):938-48. PubMed ID: 3417566
[TBL] [Abstract][Full Text] [Related]
5. Repromicin derivatives with potent antibacterial activity against Pasteurella multocida.
McFarland JW; Hecker SJ; Jaynes BH; Jefson MR; Lundy KM; Vu CB; Glazer EA; Froshauer SA; Hayashi SF; Kamicker BJ; Reese CP; Olson JA
J Med Chem; 1997 Mar; 40(6):1041-5. PubMed ID: 9083494
[TBL] [Abstract][Full Text] [Related]
6. Single-dose treatment of neonatal calf pneumonia with the new macrolide antibiotic tilmicosin.
Ose EE; Tonkinson LV
Vet Rec; 1988 Oct; 123(14):367-9. PubMed ID: 3195026
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, antimicrobial activity and in vivo fluorine NMR of a hexafluorinated derivative of tilmicosin.
Creemer LC; Kirst HA; Shryock TR; Campbell JB; Webb AG
J Antibiot (Tokyo); 1995 Jul; 48(7):671-5. PubMed ID: 7649867
[TBL] [Abstract][Full Text] [Related]
8. Minimum inhibitory concentration breakpoints and disk diffusion inhibitory zone interpretive criteria for tilmicosin susceptibility testing against Pasteurella spp. associated with bovine respiratory disease.
Shryock TR; White DW; Staples JM; Werner CS
J Vet Diagn Invest; 1996 Jul; 8(3):337-44. PubMed ID: 8844577
[TBL] [Abstract][Full Text] [Related]
9. Effect of a new macrolide antibiotic (tilmicosin) on pneumonia experimentally induced in calves by Mycoplasma bovis and Pasteurella haemolytica.
Gourlay RN; Thomas LH; Wyld SG; Smith CJ
Res Vet Sci; 1989 Jul; 47(1):84-9. PubMed ID: 2772410
[TBL] [Abstract][Full Text] [Related]
10. The minimum inhibitory concentration of tilmicosin and tylosin for mycoplasma gallisepticum and Mycoplasma synoviae and a comparison of their efficacy in the control of Mycoplasma gallisepticum infection in broiler chicks.
Jordan FT; Horrocks BK
Avian Dis; 1996; 40(2):326-34. PubMed ID: 8790882
[TBL] [Abstract][Full Text] [Related]
11. Relationship of in vitro minimum inhibitory concentrations of tilmicosin against Mannheimia haemolytica and Pasteurella multocida and in vivo tilmicosin treatment outcome among calves with signs of bovine respiratory disease.
McClary DG; Loneragan GH; Shryock TR; Carter BL; Guthrie CA; Corbin MJ; Mechor GD
J Am Vet Med Assoc; 2011 Jul; 239(1):129-35. PubMed ID: 21718206
[TBL] [Abstract][Full Text] [Related]
12. Chemical modification of tylosin: synthesis of amino derivatives at C-20 position of tylosin and demycarosyltylosin.
Matsubara H; Inokoshi J; Nakagawa A; Tanaka H; Omura S
J Antibiot (Tokyo); 1983 Dec; 36(12):1713-21. PubMed ID: 6662813
[TBL] [Abstract][Full Text] [Related]
13. In-vitro antibacterial properties of tilmicosin against Australian isolates of Pasteurella multocida and Pasteurella haemolytica from cattle.
Stephens CP; Blackall PJ; Wade LK; Lowe LB
Aust Vet J; 1993 Oct; 70(10):391-2. PubMed ID: 8257321
[No Abstract] [Full Text] [Related]
14. Postantibiotic effects and postantibiotic sub-MIC effects of erythromycin, roxithromycin, tilmicosin, and tylosin on Pasteurella multocida.
Lim J; Yun H
Int J Antimicrob Agents; 2001 Jun; 17(6):471-6. PubMed ID: 11397617
[TBL] [Abstract][Full Text] [Related]
15. New amidino-benzimidazolyl derivatives of tylosin and desmycosin.
Hranjec M; Starcević K; Zamola B; Mutak S; Derek M; Karminski-Zamola G
J Antibiot (Tokyo); 2002 Mar; 55(3):308-14. PubMed ID: 12014447
[TBL] [Abstract][Full Text] [Related]
16. Comparison between the minimal inhibitory concentration of tilmicosin and oxytetracycline for bovine pneumonic Pasteurella haemolytica isolates.
Hartman EG; Geryl J
Vet Q; 1993 Dec; 15(4):184. PubMed ID: 8122359
[TBL] [Abstract][Full Text] [Related]
17. Postantibiotic and physiological effects of tilmicosin, tylosin, and apramycin at subminimal and suprainhibitory concentrations on some swine and bovine respiratory tract pathogens.
Diarra MS; Malouin F; Jacques M
Int J Antimicrob Agents; 1999 Aug; 12(3):229-37. PubMed ID: 10461841
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of tylosin-related macrolides modified at the aldehyde function: a new series of orally effective antibiotics.
Kirst HA; Toth JE; Debono M; Willard KE; Truedell BA; Ott JL; Counter FT; Felty-Duckworth AM; Pekarek RS
J Med Chem; 1988 Aug; 31(8):1631-41. PubMed ID: 3398001
[TBL] [Abstract][Full Text] [Related]
19. Use of tilmicosin for treatment of pasteurellosis in rabbits.
McKay SG; Morck DW; Merrill JK; Olson ME; Chan SC; Pap KM
Am J Vet Res; 1996 Aug; 57(8):1180-4. PubMed ID: 8836371
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial activity of tilmicosin against Pasteurella multocida and Actinobacillus pleuropneumoniae isolated from pneumonic lesions in swine.
Inamoto T; Kikuchi K; Iijima H; Kawashima Y; Nakai Y; Ogimoto K
J Vet Med Sci; 1994 Oct; 56(5):917-21. PubMed ID: 7865594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
